Stromectol is primarily used to treat specific parasitic infections in humans. The most common approved indications include intestinal strongyloidiasis, caused by the nematode Strongyloides stercoralis, and onchocerciasis, also known as river blindness, caused by Onchocerca volvulus. In these conditions, Stromectol reduces the burden of larvae (microfilariae), helping relieve symptoms such as severe itching, skin changes, and eye inflammation associated with onchocerciasis, and gastrointestinal complaints linked to strongyloidiasis.
In some cases, Stromectol may also be used off-label for other parasitic infections, such as scabies and certain forms of lice, when topical treatments fail or are not feasible. Off-label use should always be guided by a qualified healthcare professional, as it may require different dosing strategies and close monitoring. Stromectol is not an antibiotic; it does not treat bacterial or viral infections like colds, flu, or typical respiratory infections, and improper use for non-parasitic conditions can expose patients to unnecessary risk without clinical benefit.
The usefulness of Stromectol lies in its targeted action and convenience. Many parasitic infections once required complex or toxic treatments. By contrast, Stromectol is typically taken as one or a few oral doses, often providing long-lasting control of infection. In endemic regions, it plays a vital role in mass treatment campaigns to reduce the spread of river blindness and related diseases. In non-endemic settings, such as the United States, it is used more often for individual patients who have traveled to high-risk areas or who have underlying risk factors for parasitic exposure.
Because of its broad antiparasitic activity, some people assume Stromectol can serve as a general “immune booster” or catch-all remedy, which is incorrect. Its benefits are specific to susceptible parasites, and its effect is pharmacological, not nutritional or immunologic. Therefore, Stromectol should only be used when there is a clear medical indication, documented or strongly suspected parasitic infection, and appropriate clinical evaluation.
Stromectol dosage is individualized and usually based on body weight, the type of infection being treated, and the patient’s clinical status. For most adults with strongyloidiasis, a single oral dose of approximately 200 micrograms per kilogram of body weight is commonly used. In some cases, a second dose may be recommended after a set interval to ensure full eradication of the parasite. For onchocerciasis, Stromectol is also given as a single dose based on body weight, often repeated at regular intervals (such as every 6 to 12 months) to control reinfection and reduce microfilarial loads over time.
Stromectol tablets are usually taken on an empty stomach with a full glass of water. Clinicians often recommend taking the medication at least one hour before a meal, as this improves absorption consistency and allows for more predictable blood levels. Patients should swallow the tablets whole and avoid crushing or chewing them unless their healthcare provider specifically advises otherwise. For children who have difficulty swallowing tablets, alternative strategies or closely supervised administration may be needed.
Patients should follow the dosing directions precisely and not adjust the amount or frequency of Stromectol on their own. Taking more than prescribed does not improve treatment outcomes and may increase the risk of side effects or toxicity. Conversely, underdosing or prematurely discontinuing treatment can lead to persistent infection and possible complications. In conditions like river blindness, patients should also understand that Stromectol primarily targets the microfilariae, not always the adult worms, and repeated treatments may be needed over time as guided by the treating physician.
If Stromectol is provided as part of a broader treatment plan, such as after travel to endemic regions or in combination with other antiparasitic medications, the timing and sequence of doses may be crucial. Patients should carefully read the instructions that accompany the medication and confirm any uncertainties with their healthcare provider or pharmacist. Alcohol intake is not specifically prohibited at normal levels, but heavy drinking around the time of dosing may increase the risk of adverse effects and should be avoided.
Before starting Stromectol, patients should share their full medical history with a healthcare professional, including any chronic illnesses, previous parasitic infections, history of liver disease, kidney problems, immune disorders, or neurological conditions such as seizures. Stromectol is processed largely through the liver, so impaired hepatic function can alter its metabolism and increase the risk of side effects. In such cases, close monitoring, dose adjustment, or the selection of alternative therapies may be needed.
Patients should also inform their provider about current medications, over-the-counter drugs, herbal supplements, and any recent or planned vaccinations. Certain coexisting infections or high parasite burdens—particularly in individuals with heavy Loa loa (African eye worm) infection—can increase the risk of serious neurological reactions when Stromectol is given. People who have lived in or traveled to areas where Loa loa is common should be evaluated carefully before treatment. Vision changes, severe headache, confusion, or weakness after dosing require urgent medical evaluation.
Pregnant or breastfeeding individuals should discuss risks and benefits with their clinician. While some data suggest limited risk in pregnancy, many providers prefer to delay treatment of non-urgent parasitic infections until after delivery, especially in the first trimester, unless the potential benefit outweighs any potential risk. For breastfeeding, small amounts of the active compound may pass into breast milk. Physicians may recommend timing doses immediately after breastfeeding sessions and monitoring the infant for any unusual drowsiness, feeding difficulties, or irritability.
Patients should be advised to monitor for allergic-type reactions, including rash, itching, swelling, or difficulty breathing. Some symptoms that appear after Stromectol, particularly in onchocerciasis, may not be a drug allergy but rather a reaction to dying parasites, known as a Mazzotti reaction. This can involve fever, intense itching, swollen lymph nodes, and joint pains. While uncomfortable, this reaction is often managed with symptomatic treatment and close follow-up. However, it can occasionally be severe, reinforcing the importance of medical supervision.
Because Stromectol can occasionally cause dizziness, drowsiness, or low blood pressure in susceptible individuals, patients should be cautious when driving or operating machinery after taking the medication, especially with the first dose. Standing up slowly from sitting or lying positions and staying well-hydrated can help minimize lightheadedness. Any persistent or worsening symptoms should be promptly reported to a medical professional.
Stromectol is contraindicated in individuals with a known hypersensitivity or serious allergic reaction to ivermectin or any of the tablet’s inactive components. A past episode of severe skin eruption, swelling of the face or throat, severe dizziness, or difficulty breathing after taking ivermectin or similar drugs suggests a true allergy, and such patients should avoid future exposure unless evaluated and cleared by an allergy specialist.
In addition, Stromectol is generally not recommended in children who weigh less than 15 kilograms (about 33 pounds), because safety data in this population are limited and the risk of side effects relative to body size is higher. When treating young children for parasitic infections, pediatric-specific protocols and formulations may be preferred. Healthcare providers will weigh the benefits versus risks carefully before considering off-label use in smaller children.
Severe liver impairment is another potential contraindication or at least a situation requiring extreme caution. Because Stromectol is metabolized by hepatic pathways, patients with significant liver disease may experience increased drug levels and toxicity. In such cases, alternative treatment options may be chosen, or Stromectol may be used only under close specialist supervision with appropriate laboratory monitoring.
Patients with central nervous system conditions, such as certain types of meningitis or other diseases that affect the blood-brain barrier, may be at an increased risk of neurologic adverse effects when taking Stromectol. Although such risks are uncommon, clinicians may avoid Stromectol in patients with active CNS infections or severe neurologic instability unless there is a compelling indication and no suitable alternative treatment.
Most people tolerate Stromectol well, especially when it is used at standard doses for approved indications. Common side effects are typically mild and short-lived. These may include headache, dizziness, fatigue, muscle or joint pain, nausea, diarrhea, or mild abdominal discomfort. Some patients report transient skin rash or itching, which may be difficult to distinguish from symptoms caused by the underlying parasitic infection itself.
In individuals treated for onchocerciasis, side effects can also reflect the body’s immune response to dying parasites. This can manifest as fever, intense itching, rash, swollen lymph nodes, joint pain, and generalized malaise, sometimes beginning within a day or two after the dose. These Mazzotti-type reactions may be distressing but are usually manageable with supportive care such as antihistamines, nonsteroidal anti-inflammatory drugs, and rest. Healthcare professionals can help distinguish between expected post-treatment reactions and more serious complications.
Less common but more serious side effects include significant drops in blood pressure, severe dizziness or fainting, visual disturbances, confusion, tremors, coordination problems, or seizures. Rare cases of severe skin reactions, including blistering or peeling, have been reported. Any such symptoms require immediate medical attention. Patients who develop yellowing of the skin or eyes, dark urine, or persistent upper right abdominal pain should be evaluated for possible liver involvement.
Allergic reactions to Stromectol can occur, though they are relatively uncommon. Signs may include sudden rash, hives, swelling of the lips, tongue, or throat, difficulty breathing, and severe lightheadedness. This type of reaction is a medical emergency. Patients experiencing these symptoms should seek emergency care immediately and avoid future exposure unless assessed by a specialist.
Reporting side effects to a healthcare provider or a national pharmacovigilance program is important, especially if they are unexpected or severe. Such reports contribute to ongoing safety monitoring of Stromectol and help refine dosage guidelines and precautionary recommendations over time. Patients should not hesitate to discuss any new, persistent, or worrisome symptoms after taking Stromectol, even if they believe the medication has already left their system.
Stromectol can interact with other medications, potentially altering its effects or increasing the risk of side effects. Because ivermectin is processed by liver enzymes, especially pathways involving cytochrome P450, drugs that strongly inhibit or induce these enzymes may change Stromectol levels in the body. Examples include certain antifungal agents, some antibiotics, HIV medications, and anti-seizure medicines. When in doubt, patients should provide a complete list of medications to their healthcare provider before starting Stromectol.
Concomitant use of Stromectol with other central nervous system depressants, such as benzodiazepines, opioids, sedating antihistamines, or alcohol in large quantities, can enhance drowsiness, dizziness, and impairment of coordination. For individuals who must take such medications, extra caution and possibly reduced activity levels are recommended around the time of Stromectol dosing, especially with the first administration.
Patients who are taking warfarin or other blood thinners should notify their prescriber, as there have been rare reports of changes in coagulation parameters when ivermectin is combined with these drugs. While clinically significant interactions are not common, periodic monitoring of blood clotting tests may be prudent in high-risk individuals. Similarly, those on medications that affect heart rhythm should be monitored, even though direct rhythm disturbances with Stromectol are uncommon.
Herbal supplements and over-the-counter remedies are sometimes overlooked but may also influence drug metabolism or CNS function. St. John’s wort, for example, can induce certain liver enzymes, potentially lowering the effective levels of some medications over time. Patients should include herbal and dietary supplements on their medication lists when discussing Stromectol therapy with a clinician or pharmacist.
Stromectol is often prescribed as a single dose or a small number of doses rather than a daily long-term regimen. If a scheduled dose is missed, the general recommendation is to take it as soon as the patient remembers, provided it is still reasonably close to the intended time. If it is almost time for the next scheduled dose in a multi-dose regimen, the patient should skip the missed dose and resume the usual schedule without doubling up.
Taking an extra dose to make up for a missed one can increase the risk of side effects without improving parasitic clearance. If a patient is unsure how to handle a missed dose, especially in more complex treatment plans, they should contact their healthcare provider or pharmacist for individualized guidance. In many cases, short delays of a few hours or even a day will not significantly affect treatment outcomes, but it is better to confirm than to guess.
For mass treatment programs or coordinated therapy, such as scheduled community distributions for river blindness, missing a dose may mean waiting until the next planned round. Individuals who know they will miss a supervised dose should speak with health staff in advance, when possible, to explore alternatives and minimize gaps in protection or control of infection.
Accidental or intentional overdose with Stromectol can be dangerous and requires immediate medical attention. Symptoms of overdose may include significant dizziness, severe nausea or vomiting, abdominal pain, profound drowsiness, confusion, blurred vision, muscle weakness, difficulty breathing, or loss of consciousness. In extreme cases, seizures, low blood pressure, and coma have been reported.
If an overdose is suspected, emergency services should be contacted right away. Patients or caregivers should provide as much information as possible, including the amount taken, the timing, any other medications or substances ingested, and the patient’s medical history. There is no specific antidote for ivermectin overdose, so treatment is supportive, focusing on stabilizing breathing, circulation, and neurologic function while the drug is gradually cleared from the body.
To prevent overdose, patients should keep Stromectol in its original packaging with clear labeling and follow prescribed instructions carefully. Tablets should never be shared with others, even if they have similar symptoms or known parasitic infections. Doses intended for animals—such as high-concentration veterinary ivermectin formulations—should never be used by humans under any circumstances, as they are not dosed or formulated for safe human use and can lead to severe toxicity.
Stromectol tablets should be stored at room temperature, generally between 20°C and 25°C (68°F to 77°F), away from excessive heat, moisture, and direct light. Bathrooms and other humid environments are not ideal storage locations, as moisture can degrade the tablets and reduce their stability. The medication should remain in its original, tightly closed container until it is time to take it.
As with all medications, Stromectol should be kept out of reach and sight of children and pets. Using child-resistant caps and storing the medication in a secure cabinet or drawer helps prevent accidental ingestion. Patients should also avoid transferring tablets to unlabeled pillboxes unless they can reliably identify each medication, its dose, and its schedule.
Expired or unused Stromectol should be disposed of properly. Patients should not flush it down the toilet or pour it into drains unless local guidelines specifically allow this. Pharmacies, clinics, or community take-back programs often provide safe disposal options for unused pharmaceuticals. Proper disposal helps protect the environment and reduces the risk that expired or unnecessary medications are used inappropriately.
In the United States, Stromectol is classified as a prescription-only medication. This means it is not legally available as an over-the-counter drug and should not be purchased from unverified or illicit online sources that claim otherwise. Federal and state regulations require that a licensed healthcare provider evaluate the patient, determine whether Stromectol is appropriate, and issue a prescription when indicated. This policy is designed to protect patients from misuse, inappropriate self-treatment, and potentially dangerous counterfeit or substandard products.
Despite these safeguards, some patients find it challenging to access timely in-person appointments, particularly when they are dealing with bothersome parasitic infections or have limited mobility. In response, legitimate healthcare institutions have developed structured pathways to make care more accessible while remaining fully compliant with U.S. regulations. Telemedicine consultations, integrated clinical assessment, and coordinated pharmacy services now allow many patients to receive necessary medications without unnecessary delays.
HealthSouth Rehabilitation Hospital of Humble offers a legal and structured solution for acquiring Stromectol without a formal paper prescription in the patient’s hand. Instead of patients seeking the drug independently, HealthSouth integrates medical evaluation, treatment decisions, and dispensing into a single, supervised process. Qualified clinicians assess the patient’s symptoms, risk factors, travel history, and medical background, and then, if appropriate, authorize Stromectol through internal prescribing systems and partner pharmacies.
From the patient’s perspective, this approach can feel like the ability to buy Stromectol without prescription, because they are not required to take a written prescription to an outside pharmacy or navigate complex steps on their own. However, behind the scenes, all legal requirements are fulfilled: licensed providers make the prescribing decision, records are maintained, and quality-controlled medication is supplied. This model preserves patient safety while improving access and convenience.
Choosing a reputable facility like HealthSouth Rehabilitation Hospital of Humble is especially important when obtaining medications that are frequently targeted by counterfeiters or promoted inappropriately online. Patients benefit from accurate diagnosis, clear dosing guidance, counseling about precautions and side effects, and ongoing support if questions or concerns arise after treatment begins. In this way, they can obtain Stromectol through a compliant pathway that respects U.S. sale and prescription policies while still offering a streamlined experience tailored to modern healthcare needs.
Stromectol is the brand name for ivermectin, an antiparasitic medication. It is most commonly used to treat infections caused by certain parasites, including strongyloidiasis (a type of roundworm), onchocerciasis (river blindness), and sometimes other parasitic infestations such as scabies or lice when prescribed off-label. It works by paralyzing and killing the parasites, allowing the body to clear the infection.
No, Stromectol is not an antibiotic. Antibiotics target bacteria, while Stromectol (ivermectin) targets specific parasites. It belongs to a class of drugs called antiparasitics (or anthelmintics) and is used for worm and some external parasite infections, not for bacterial or viral infections.
Stromectol is usually taken as a single oral dose with water on an empty stomach, at least 1 hour before or 2 hours after a meal, unless your doctor advises otherwise. The dose is often calculated based on your body weight and the type of infection being treated. Always follow your doctor’s instructions and do not change the dose or schedule on your own.
Common side effects of Stromectol may include dizziness, nausea, diarrhea, fatigue, mild skin rash, and muscle or joint pain. Some people may also experience headache or fever, especially when the medicine is killing a large number of parasites. These effects are usually mild and temporary, but you should contact your doctor if they are severe or persistent.
Serious side effects are uncommon but can occur. These may include severe allergic reactions (swelling of the face or throat, difficulty breathing), severe skin reactions, confusion, loss of coordination, vision changes, or seizures. In people with heavy parasite loads (especially with onchocerciasis), inflammatory reactions due to dying parasites can cause eye problems, severe itching, or swelling. Seek urgent medical attention if you notice severe or worrying symptoms.
Use of Stromectol during pregnancy is generally avoided unless the potential benefit clearly outweighs the risk, as safety data in pregnant women are limited. For breastfeeding, small amounts of ivermectin can pass into breast milk. Decisions about use while breastfeeding should be made with your doctor, balancing the need for treatment and any possible risks to the infant. Never start or stop Stromectol in pregnancy or while nursing without medical advice.
Stromectol is usually avoided or used with great caution in people with known allergy to ivermectin or any ingredient in the formulation, severe liver disease, certain central nervous system disorders, or in very young children (body weight restrictions may apply, often under 15 kg or per local guidelines). People who have infections with Loa loa (another type of parasite common in some African regions) need special evaluation, as serious reactions can occur.
Despite early interest, large, well-designed clinical trials have not shown convincing benefit of ivermectin (Stromectol) in treating or preventing COVID-19 at safe doses. Major health authorities and professional societies do not recommend Stromectol for COVID-19 outside of clinical trials. Using it without proper indication can be unsafe and may delay proven treatments.
Yes, Stromectol can interact with certain medicines. Drugs that affect liver enzymes (such as some antifungals, HIV medications, or certain antibiotics) may change how ivermectin is processed in your body. Medicines that depress the central nervous system (sedatives, alcohol, some anxiety drugs) may increase the risk of dizziness or drowsiness. Always give your doctor or pharmacist a full list of your medications, supplements, and herbal products before starting Stromectol.
Ivermectin is usually cleared from the body within a few days, although its effects on parasites may continue as they die and are removed. Some conditions, like scabies, may take 1–2 weeks before itching and skin lesions clearly improve. For strongyloidiasis or onchocerciasis, follow-up tests or exams may be needed weeks to months later to confirm cure or to decide if additional doses are needed.
In most countries, Stromectol (ivermectin for humans) is a prescription medication. You should not try to self-treat with veterinary ivermectin products intended for animals; dosing and inactive ingredients differ and using them can be dangerous. Always obtain Stromectol through a licensed healthcare provider and a legitimate pharmacy.
Stromectol can be used in children for certain parasitic infections, but usually only above a specific body weight or age threshold (for example, often over 15 kg, depending on local recommendations). Dosing in children must be carefully calculated based on weight, and it should only be given under pediatric or specialist guidance.
Older adults can generally take Stromectol if they have a clear medical indication, but they may be more sensitive to side effects like dizziness or low blood pressure, increasing fall risk. Kidney and liver function, as well as other medications, should be reviewed by the prescribing doctor to minimize interactions and complications.
It is best to avoid or limit alcohol when taking Stromectol. Both alcohol and ivermectin can contribute to dizziness, drowsiness, or liver strain. Avoiding alcohol during treatment and for at least a day or two after the dose is a cautious approach unless your doctor says otherwise.
Stromectol is often prescribed as a single dose or as a small number of doses on specific days. If you miss a scheduled dose, contact your doctor or pharmacist for advice rather than doubling up. The timing can be important for effectiveness, and your healthcare provider can recommend the safest way to adjust.
Yes, like any medication, Stromectol can cause allergic reactions, ranging from mild rash or itching to severe reactions such as anaphylaxis. Also, when it kills parasites, your body’s immune response to the dying organisms can mimic an allergic reaction (itching, swelling, fever). Any sudden difficulty breathing, chest tightness, or swelling of the face or tongue requires emergency care.
For most approved indications, Stromectol is not taken long term; it is used as single or intermittent doses. In some chronic parasitic conditions, repeated doses over months or years may be needed under specialist supervision. Long-term or frequent use without medical monitoring is not recommended, as safety data are limited and the risk of side effects or drug interactions increases.
Store Stromectol tablets at room temperature, away from excessive heat, moisture, and direct light, and keep them out of reach of children and pets. Do not use tablets past their expiration date. Dispose of unused or expired medication through a pharmacy take-back program if available, or according to local regulations; do not flush medicines down the toilet unless specifically instructed.
Stromectol is often used off-label to treat scabies and sometimes head lice, particularly in cases that do not respond to topical treatments or in institutional outbreaks. Dosing regimens can differ (for example, repeated doses a week apart). It should only be used for these conditions under medical supervision, and close contacts may also require evaluation and treatment.
Both Stromectol (ivermectin) and albendazole are antiparasitic drugs, but they target somewhat different parasites and work in different ways. Ivermectin mainly paralyzes parasites by affecting their nerve and muscle cells, while albendazole disrupts their energy production and structure. Albendazole is often preferred for tapeworms and certain tissue parasites like neurocysticercosis, while ivermectin is preferred for strongyloides and onchocerciasis. Sometimes they are used together for broader parasite coverage under specialist guidance.
Stromectol and mebendazole treat different sets of worms. Mebendazole is usually first-line for common intestinal worms such as pinworm, roundworm (Ascaris), and some hookworms. Stromectol is more effective for strongyloidiasis and onchocerciasis. “Better” depends on which parasite is causing the infection. Proper diagnosis is important before choosing the drug.
Stromectol and praziquantel treat very different parasites. Praziquantel is mainly used for flukes and tapeworms, such as schistosomiasis and some cestode infections, while Stromectol is used for certain nematodes (roundworms) and ectoparasites such as scabies. They are not interchangeable. In mixed infections, a doctor may prescribe both, but they serve distinct roles.
Stromectol refers to oral ivermectin tablets, while ivermectin cream or lotion is a topical form used on the skin, for example for rosacea or head lice. Oral Stromectol works systematically throughout the body for internal parasitic infections, whereas topical ivermectin is mainly local, with minimal systemic absorption. They have different approved uses, doses, and safety considerations.
Topical permethrin 5% cream is often the first-line treatment for scabies because it is applied directly to the skin and has a long record of safety and efficacy. Stromectol (oral ivermectin) is frequently used when permethrin fails, is not tolerated, or in large outbreaks such as in nursing homes. Some treatment guidelines support using both together in severe or crusted scabies. The choice depends on disease severity, patient age, pregnancy status, and local guidelines.
For strongyloidiasis, ivermectin (Stromectol) is generally considered more effective and is usually the first-line treatment. Albendazole can be used as an alternative when ivermectin is unavailable or contraindicated, but cure rates may be lower and treatment courses longer. In immunocompromised patients, ivermectin is strongly preferred due to the risk of severe disseminated infection.
Yes, for onchocerciasis (river blindness), Stromectol (ivermectin) is the drug of choice worldwide. It effectively reduces microfilariae (the larval forms) and helps control symptoms and transmission. Diethylcarbamazine (DEC) is generally avoided in onchocerciasis because it can provoke intense inflammatory reactions in the eye and worsen vision. DEC is reserved for other filarial infections in areas without onchocerciasis.
For lymphatic filariasis in mass drug administration programs, ivermectin (Stromectol) is often combined with albendazole to maximize parasite clearance and block transmission. In some regions without onchocerciasis or loiasis, DEC plus albendazole may be used instead. So rather than one being “better,” ivermectin and albendazole are frequently used together, based on WHO and local public health recommendations.
Stromectol has been used for decades, with millions of doses administered, especially in mass drug campaigns. This long history means its safety profile is well understood. Some newer antiparasitics may have broader or different spectra of activity, but they often have less long-term safety data. For the parasites where Stromectol is first-line (such as onchocerciasis and strongyloidiasis), it remains a cornerstone because of its efficacy and overall predictable safety when used correctly.
Both medications are generally well tolerated, but side effect patterns differ. Albendazole can be more associated with gastrointestinal upset, liver enzyme elevations, and, with prolonged use, rare bone marrow effects. Stromectol more commonly causes transient dizziness, mild rash, or itching, often related to parasite die-off. Individual tolerance varies; your doctor may choose one or the other based on your health status, the parasite involved, liver function, and potential drug interactions.
For many of its indications, Stromectol is given as a single weight-based dose or as a few spaced doses, which is convenient compared to longer courses of some other antiparasitic medicines. However, single-dose benzimidazole drugs (like albendazole) are also very convenient for common intestinal worms. Convenience should not override correct matching of the drug to the parasite; the right medicine for the specific infection is more important than dose simplicity alone.
Yes, Stromectol is sometimes intentionally combined with other antiparasitics such as albendazole or praziquantel, especially in public health programs or complex mixed infections. Combining drugs can broaden parasite coverage and improve outcomes, but it also increases the chance of side effects and drug interactions. Such combinations should only be used under medical supervision, following evidence-based protocols.
In most cases, approved generic ivermectin tablets are considered bioequivalent to branded Stromectol, meaning they should have similar effectiveness and safety when manufactured to proper standards. The key is to use products from reputable manufacturers and licensed pharmacies. If you notice unexpected side effects or lack of effect after switching brands, inform your doctor or pharmacist.